Verification of the fetal valproate syndrome phenotype. - Wikidata - wikimedia - TriplyDB

Verification of the fetal valproate syndrome phenotype.

Verification of the fetal valproate syndrome phenotype.

http://www.wikidata.org/entity/Q34166934

about

Treatment for epilepsy in pregnancy: neurodevelopmental outcomes in the child Treatment for epilepsy in pregnancy: neurodevelopmental outcomes in the child A clinical study of 57 children with fetal anticonvulsant syndromes Exploring the Validity of Valproic Acid Animal Model of Autism Metopic synostosis Lack of Serologic Evidence for an Association between Cache Valley Virus Infection and Anencephaly and other Neural Tube Defects in Texas Epilepsy during pregnancy: focus on management strategies Embryological origin for autism: developmental anomalies of the cranial nerve motor nuclei Dysmorphology demystified Valproic acid prenatal exposure. Association with lipomyelomeningocele Fetal valproate phenotype is recognisable by mid pregnancy.Fetal anticonvulsant syndrome and mutation in the maternal MTHFR gene Malformations, withdrawal manifestations, and hypoglycaemia after exposure to valproate in utero.Social Preference Deficits in Juvenile Zebrafish Induced by Early Chronic Exposure to Sodium Valproate Definition of transcriptome-based indices for quantitative characterization of chemically disturbed stem cell development: introduction of the STOP-Toxukn and STOP-Toxukk tests.Impact of early life exposure to antiepileptic drugs on neurobehavioral outcomes based on laboratory animal and clinical research.Mouse models of autism: testing hypotheses about molecular mechanisms.Prenatal VPA Exposure and Changes in Sensory Processing by the Superior Colliculus Fetal valproate syndrome.Valproic acid use in psychiatry: issues in treating women of reproductive age.The prevalence of neurodevelopmental disorders in children prenatally exposed to antiepileptic drugs Focus on apoptosis to decipher how alcohol and many other drugs disrupt brain development.The effects of lithium, valproic acid, and carbamazepine during pregnancy and lactation.Syndromal and nonsyndromal primary trigonocephaly: analysis of a series of 237 patients.Septo-optic dysplasia as a manifestation of valproic acid embryopathy.Monotherapy treatment of epilepsy in pregnancy: congenital malformation outcomes in the child.Laser light scan analysis of the "anticonvulsant face".The intense world syndrome--an alternative hypothesis for autism Teratogen-induced limb defects.A prospective study of cognitive fluency and originality in children exposed in utero to carbamazepine, lamotrigine, or valproate monotherapy.Craniosynostosis and nutrient intake during pregnancy IQ at 6 years after in utero exposure to antiepileptic drugs: a controlled cohort study Long term health and neurodevelopment in children exposed to antiepileptic drugs before birth.The pharmacology of bipolar disorder during pregnancy and breastfeeding.Early Behavioral Abnormalities and Perinatal Alterations of PTEN/AKT Pathway in Valproic Acid Autism Model Mice.Teratogenicity of sodium valproate.Prophylactic treatment of bipolar disorder in pregnancy and breastfeeding: focus on emerging mood stabilizers.Cognitive/behavioral teratogenetic effects of antiepileptic drugs.The RNA binding protein HuR determines the differential translation of autism-associated FoxP subfamily members in the developing neocortex.The histone deacetylase inhibitor sodium valproate causes limited transcriptional change in mouse embryonic stem cells but selectively overrides Polycomb-mediated Hoxb silencing

P2860

Q24193032-C1AB6CA6-8C86-415C-B6A9-ED4620D236CB Q24197594-31D7A453-982C-447F-B01B-1D0DAE229182 Q24681122-CD217984-F28A-42E6-8148-D082BE278C8B Q26771764-25DAE546-3852-40C2-9A6C-22B6AB65A484 Q26823808-1AC8B5F7-C867-4C3C-9291-0E47A1E8A2B5 Q27487589-EA4675D9-4C7A-4E96-94F5-048574872098 Q28080299-584C39FE-4E02-49BE-ABDA-70CF82126B81 Q28289949-B101A92C-5D54-408F-98B5-49F305DF6FBA Q28298817-A7F7B91B-174B-455C-A1AA-846D7CDDB5C8 Q28340641-802F9B85-749C-4F60-A5A0-928D0ED5403C Q28340841-40527E15-8876-44BB-83FC-4901C9D7593B Q28376491-4C12831D-E2A6-492C-93E0-DC9B81382C3E Q28378312-E84C216D-BB4A-4545-B0F1-16AB728FE24E Q28597127-9BEE252C-817E-40AD-84D5-5BE8A3C82B9C Q29248402-903D5234-0B79-4881-B757-1B01CDFC3B7D Q30443028-CEB887D9-9D25-4ABA-B0B7-2A3A9FCB54E3 Q30465721-D1EA5BAE-17ED-4846-86CB-9552156926F2 Q30473609-80FC4247-0C3F-4D14-A7D0-41563C87AD19 Q33682465-91407A1D-FA1F-4294-873D-59AC9620452E Q33922097-B5A5C296-80FA-40AB-8BB9-AEF5E1FD1699 Q33970119-2EC26218-40A8-4163-AD81-0D50198C70BA Q33997437-33CD814C-07A7-4A34-95CF-53BDFE7A41B5 Q34349772-014E95FA-9B09-481F-816E-C7249B3A6A9B Q34454743-28B03A67-3995-46E9-B01E-4F1A56EAE2AA Q34516439-422DD45C-8F4B-4DB6-B27F-321BC58CE50E Q34544208-D13DCCD1-0900-483A-96D6-CA7A09BF5E3A Q34580137-96AA61FB-1B12-4613-A188-F722AC6E101C Q34871941-8888DEBF-F1ED-41C9-A034-A0803F6662FE Q34926892-AFA38C7E-B7AA-42D6-BF90-F25A47C5F2A8 Q35011452-F3A7FCDB-986D-4E5E-BBDD-A3714A1387CE Q35105873-85727E07-FD46-427E-9FDF-B99E1B1E1333 Q35106308-4A2C6E93-D123-4B31-83E1-B6C88BD102D2 Q35439268-CA50E421-31C4-4835-B27E-0791C117F4CF Q35779335-2B8BE0EF-8D42-4718-A3A2-89E41B4A115C Q35987367-478BC346-EACC-4113-97BA-DEA1954FF4D0 Q36082034-65A5B13F-3CDB-4CFA-AF80-312E47C2DCEA Q36476778-A25300B1-017E-4F5A-8245-7A89C29FB37A Q36998336-52EBF042-746F-4AF4-9655-366BD271144C Q37072624-E33DC202-6F48-4C90-8102-ABFDA63447EC Q37160553-B080F867-5F23-4B20-ABBA-53DECFF7A5D9

P2860

Verification of the fetal valproate syndrome phenotype.

http://www.wikidata.org/entity/Q34166934

description

1988 nî lūn-bûn

@nan

1988 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

1988 թվականի հունվարին հրատարակված գիտական հոդված

@hy

1988年の論文

@ja

1988年論文

@yue

1988年論文

@zh-hant

1988年論文

@zh-hk

1988年論文

@zh-mo

1988年論文

@zh-tw

1988年论文

@wuu

name

Verification of the fetal valproate syndrome phenotype.

@ast

Verification of the fetal valproate syndrome phenotype.

@en

Verification of the fetal valproate syndrome phenotype.

@nl

type

label

Verification of the fetal valproate syndrome phenotype.

@ast

Verification of the fetal valproate syndrome phenotype.

@en

Verification of the fetal valproate syndrome phenotype.

@nl

prefLabel

Verification of the fetal valproate syndrome phenotype.

@ast

Verification of the fetal valproate syndrome phenotype.

@en

Verification of the fetal valproate syndrome phenotype.

@nl

P1433

Q34166934-2A63BEE3-3049-4B16-961F-7C7597C407FC

P1476

Q34166934-B71FDABE-69F0-4727-95FF-AACF3BADAC21

P2093

Q34166934-1DF907C8-6FA3-44A4-81F2-2880FE57B190

Q34166934-38916FBA-374D-46EE-AAF8-454E23CC5C25

Q34166934-41954332-9E1B-4694-A04C-C8F3AE2B2709

Q34166934-4CE62839-DD6C-4926-930F-6BD411F275A2

Q34166934-5D955880-273F-4D04-BB97-F5543567E1A5

Q34166934-72BE8325-01A6-4531-A757-F94387A9C051

Q34166934-8AA79C7D-9474-49DF-9197-D0C63F3B35C9

Q34166934-9D1B1F77-C704-45B1-AC5D-97D553C26BB0

Q34166934-EE37ADE5-99F8-4CA0-8B30-B9A4E997D8D3

Q34166934-F855A91A-B62B-4E59-B0AB-6CC2B97645F6

P2860

Q34166934-4CE0AC59-75DB-4621-B607-CCF5F6E1BE84

Q34166934-544A87D4-5563-4D7D-BD32-865250101FE9

Q34166934-F3EBA0B3-6674-45BA-B7A2-73C663F369A7

P304

Q34166934-82799BD1-0331-483F-8D94-0F032845F80E

P31

Q34166934-0F811AA2-7E6B-454C-9925-8C6C535A1F96

P356

Q34166934-8131259C-752F-416C-A645-C2D5B97E6DFF

P433

Q34166934-51BF66EC-279F-49C0-A206-903A39F971C0

P478

Q34166934-2CE4BB53-891B-49E0-989B-4E6C4F4CB2CE

P577

Q34166934-27854F1C-A09F-49F8-9727-10B25DBD3850

P5875

Q34166934-40BD2B5E-402D-4FE2-AF83-50A005AB61F7

P698

Q34166934-AA66FEBF-1C16-4225-BF06-04BF7CF90DA6

P356

AJMG.1320290123

P1433

American Journal of Medical Genetics Part A

P1476

Verification of the fetal valproate syndrome phenotype.

@en

P2093

Ardinger HH

http://www.w3.org/2001/XMLSchema#string

Atkin JF

http://www.w3.org/2001/XMLSchema#string

Blackston RD

http://www.w3.org/2001/XMLSchema#string

Clarren SK

http://www.w3.org/2001/XMLSchema#string

Elsas LJ

http://www.w3.org/2001/XMLSchema#string

Flannery DB

http://www.w3.org/2001/XMLSchema#string

Harrod MJ

http://www.w3.org/2001/XMLSchema#string

Lammer EJ

http://www.w3.org/2001/XMLSchema#string

Livingstone S

http://www.w3.org/2001/XMLSchema#string

Pellock JM

http://www.w3.org/2001/XMLSchema#string

P2860

Valproic acid embryopathy?

Cardiac embryology. Its relevance to congenital heart disease.

Teratogenic effects of valproate in the CD-1 mouse fetus.

P304

171-185

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/AJMG.1320290123

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P577

1988-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

20030031

http://www.w3.org/2001/XMLSchema#string

P698

3125743

http://www.w3.org/2001/XMLSchema#string